Chad C Volk, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 167 Monkton Rd # 101b, Bristol, VT 05443 Phone: 802-453-7200 Fax: 802-329-2302 |
Ms. Carol Ann Price, PT, LAC Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 14 School St, Suite 103a, Bristol, VT 05443 Phone: 802-453-5999 Fax: 802-453-5999 |
Dr. Sarah Lynn Livingston, P.T., D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1531 Hardscrabble Rd, Bristol, VT 05443 Phone: 802-349-4716 |
Diane K Greenberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 167 Monkton Road, Suite 101b, Bristol, VT 05443 Phone: 802-453-7200 Fax: 802-453-7220 |
Kimberly A Clark, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 614 Monkton Rd, Bristol, VT 05443 Phone: 802-349-1808 Fax: 802-453-2988 |
News Archive
Today, the Cleveland Browns made official the partnership that makes University Hospitals in Cleveland the official health care partner of the Cleveland Browns for the next 10 years.
Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
Pevion Biotech AG today announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion's second generation virosomal vaccine platform to induce strong and long-lasting immunity in humans against otherwise weak antigens .
› Verified 7 days ago